IDEXX Laboratories revenue and financials

IDXX · NASDAQ · USD

$527.07+1.67%+$8.68

Close · October 5, 2026

In the fiscal year ended December 2025, IDEXX Laboratories reported revenue of $4.3B (+10.42% year over year). Net income was $1.06B, a net margin of 24.6%.

Annual revenue · 2025: $4.3B

$1.78B2016
$1.97B2017
$2.21B2018
$2.41B2019
$2.71B2020
$3.22B2021
$3.37B2022
$3.66B2023
$3.9B2024
$4.3B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth: +10.42%; 2025 vs 2024
Net income growth: +19.33%; 2025 vs 2024
Net margin: 24.6%; 2024: 22.8%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total revenue	4,304	3,898	3,661	3,367	3,215	2,707	2,407	2,213	1,969	1,775
Cost of revenue	1,644	1,519	1,471	1,363	1,326	1,136	1,041	972	872	800
Gross profit	2,660	2,379	2,190	2,004	1,889	1,571	1,366	1,242	1,097	975
Selling, general and administrative	1,048	1,031	902	851	—	—	—	—	—	—
Research and development	251	220	191	255	161	141	133	118	109	101
Operating income	1,360	1,128	1,097	899	932	695	553	491	413	350
EBIT	1,363	1,141	1,103	900	—	—	—	—	—	—
EBITDA	1,508	1,271	1,218	1,012	—	—	—	—	—	—
Interest expense	38.9	31.2	41.6	39.9	29.8	33.1	31.1	34.7	37.2	32.0
Pre-tax income	1,324	1,110	1,061	860	—	—	—	—	—	—
Income tax	265	222	216	181	158	79.9	94.4	80.7	118	99.8
Net income	1,059	888	845	679	745	582	428	377	263	222
Net income to common shareholders	1,059	888	845	679	—	—	—	—	—	—
Basic EPS	13.17	10.77	10.17	8.12	8.74	6.82	4.97	4.34	3.00	2.47
Diluted EPS	13.08	10.67	10.06	8.03	8.60	6.71	4.89	4.26	2.94	2.44
Average shares (basic)	80.4	82.5	83.1	83.6	—	—	—	—	—	—
Average shares (diluted)	81.0	83.2	84.0	84.6	86.6	86.7	87.5	88.5	89.6	90.9